Previous studies have stated that intravitreal anti-VEGF treatment causes increased fibrosis in proliferative diabetic retinopathy patients and AMD patients, which is due to the imbalance of VEGF with regard to other growth factors such as connective tissue growth factor [4,15,16]. The gene discussed is VEGFA; the disease is proliferative diabetic retinopathy.